Related Experiment Videos
Corrigendum: Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or
Maria Rosario1, Jonathan L French2, Nathanael L Dirks2
1Clinical Pharmacology Department, Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.
Journal of Crohn'S & Colitis
|February 1, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Endoscopic and histologic healing distribution and persistent rectosigmoiditis in moderate-to-severe ulcerative colitis.
Inflammatory bowel diseases·2026
Maintenance of Efficacy Outcomes at Week 52 among Etrasimod Induction Responders: An Analysis from the Phase 3 ELEVATE UC 52 Trial.
Digestive diseases (Basel, Switzerland)·2026
The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results From the Phase II GLADIATOR Trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
A decade of clinical data with vedolizumab: the past, present, and future.
Therapeutic advances in gastroenterology·2026
Hepatic steatosis in inflammatory bowel disease: practical questions and evidence-based answers.
Journal of Crohn's & colitis·2026
Lactate Homeostasis Disruption Potentiates TACE-Immunotherapy in Hepatocellular Carcinoma.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
DUMP Cascade-Oriented MnOx@MSN Nanoadjuvant for Subunit Vaccine Antigen Delivery and Immune Potentiation.
ACS applied bio materials·2026
Electroconvulsive Therapy and the Long-Term Risk of Dementia: Conceptual Issues, Methodological Issues, and Recent Findings.
The Journal of clinical psychiatry·2026
Venetoclax as Salvage Treatment for Relapsed/Refractory B-ALL Post-CAR-T Therapy.
Pediatric blood & cancer·2026
Mitochondrial Reprogramming Along the Gut-Brain Axis in Chemotherapy-Induced Cognitive Impairment: A Narrative Review.
Oxidative medicine and cellular longevity·2026